Skip to content

A Study to Assess the Therapeutic Efficacy of Rosmarinus Officinalis 30 in the Management of Telogen Effluvium in Females

A Randomized Single Blind Placebo Controlled Study to Assess the Therapeutic Efficacy of Rosmarinus Officinalis 30 in the Management of Telogen Effluvium in Females - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092162
Enrollment
90
Registered
2025-08-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: L650- Telogen effluvium

Interventions

Intervention1: Homoeopathic medicine Rosmarinus officinalis: 30 in centesimal scale 4 pills 1 dose once in a day empty stomach in the morning dissolved in one fourth tea cup of water for 3 months Rout

Sponsors

Swasthya Kalyan Homoeopathic Medical College and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 New and Pre Diagnosed cases of Telogen Effluvium 2 Females between age group 18 to 60 years 3 Patients with history of hair fall after Physiological stress like Febrile Illness ,Surgeries ,Infection ,Childbirth but medicine will be given only when she has completely stopped breast feeding 4 Patients who are not taking any medication or those who are taking other modes or allopathic treatment and ready to stop their treatment are included. 5 Patients who are ready to give written consent.

Exclusion criteria

Exclusion criteria: 1 Pregnant women and lactating mothers will not be included in the study 2 Patients suffering from any systemic illness for example Cancer, Autoimmune diseases, Hyperthyroidism, Hypothyroidism ,Renal disease ,Liver disease or any advance pathology 3 Individuals with scalp-specific dermatological conditions such as psoriasis or seborrheic dermatitis

Design outcomes

Primary

MeasureTime frame
Assessment done on pre and post score by using Alopecia Scoring Scale and regular follow upTimepoint: 12 months

Secondary

MeasureTime frame
This study will identify the most common etiological factors responsible for Telogen Effluvium and evaluate the action of Rosmarinus officinalis against those factorsTimepoint: 12 months

Countries

India

Contacts

Public ContactDR Yogeshwari Gupta

Swasthya Kalyan Homoeopathic Medical College and Research Centre

homeopathy@swasthyakalyan.org9414229555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026